We are thrilled to announce that The Hut Group (THG) has successfully raised £116,300,000 in our latest funding round, marking a monumental milestone in our journey as a global digital commerce powerhouse. Founded in 2004 by Matthew Moulding, THG has grown from a humble start-up into a leading online retail organization in the beauty and wellbeing sectors. With a robust presence spanning more than 160 websites and reaching over 140 markets worldwide, our growth is a testament to our commitment to innovation and excellence. This impressive fundraise will not only accelerate THG’s ongoing expansion strategy but also bolster our industry-leading technology platform, THG Ingenuity. Known for its award-winning capabilities, THG Ingenuity empowers both our in-house brands—such as lookfantastic, MyProtein, ESPA, and Glossybox—and internationally renowned partners like Nintendo and Honda, ensuring seamless digital experiences that captivate millions of consumers globally. The capital influx is set to drive substantial investments in advanced digital technologies, further research and development initiatives, and scalable infrastructure, all designed to enhance our customer experience and operational efficiency. As we continue to redefine the future of e-commerce with transformational technological solutions and unparalleled product offerings, the recent funding provides a significant boost, paving the way for innovative projects and strategic market expansion. We remain dedicated to our mission of empowering consumers worldwide, and this investment reinforces THG’s promise to lead with cutting-edge digital commerce strategies while always putting the customer first. Find out more about THG and our journey at www.thg.com as we step boldly into the next chapter of our growth story.
THG Secures ÂŁ116.3 Million to Fuel Next-Gen Global Digital Commerce Expansion
Recently funded · $116.3MInternet
Get the full The Hut Group company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Clever Culture Systems
Clever Culture Systems (CCS) is an Australian Biotechnology Company and leader in microbiology technology driven by artificial intelligence. The Company is publicly listed on the Australian Securities Exchange (ASX: CC5). Using artificial intelligence (AI) to deliver automation in microbiology, the company has developed a patent protected machine learning and intelligent imaging platform technology to deliver the only FDA cleared instrument utilising AI technology in microbiology. Our technologies are designed by microbiologists for microbiologists to ensure our products not only meet the needs of the laboratory but also seamlessly integrate within our customer’s workflow. Our team are highly experienced in biotechnology, laboratory automation, diagnostics and microbiology. THE CLEVER WAY TO AUTOMATE PLATE READING The market-leading, innovative technology streamlines busy laboratory workflows, offering a modular approach. The APAS Independence is a stand-alone automated culture plate reading instrument that accurately and efficiently screens and sorts significant and insignificant growth plates at a rate of 200 plates per hour. The modular system ensures you only pay for what you need. Choose from urine, infection control (antibiotic resistance), respiratory and MRSA modules. The innovative, FDA cleared culture plate classification system identifies negative plates, allowing microbiologists to focus on the positive and significant growth plates that require their time and expertise, accelerating patient diagnosis.
$1.8M Unknown
today
